Topics: Almirall

Almirall S.A. Begins First Phase Clinical Study Of ALM223

Almirall S.A. (BME: ALM), a global pharmaceutical company focused on medical dermatology, today announced the initiation of the phase I study evaluating the safety,...

Almirall onboards Mercedes Diz as VP of Corporate Strategy

Spanish biopharmaceutical company, Almirall has announced the appointment of Mercedes Diz as Vice President (VP) of Corporate Strategy. Diz joined Almirall in 2002 and, since...

Almirall collabs with the University of Michigan to study disease drivers in hidradenitis suppurativa

Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health has today announced that “It has collaborated with the University of Michigan to...
- Advertisement -

Almirall Launches 6th call to establish partnerships in innovative therapies & skin diseases

Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on skin health, launches today its 6th call for proposals to establish collaborations in dermatological...

Trending